Fast acting New Stroke Medication, upon symptoms

The medical journal of the American Academy of Neurology has published a study that found people treated with the antibiotic minocycline within six to 24 hours after a stroke had significant fewer disabilities.

This is great news, as research welcome the alternative treatment which may allow a longer window of opportunity to treat acute stroke cases. Current treatments are only viable during the first few hours and this is usually not practical for people who do not get to the hospital in time.

New Stroke Medication fast acting

New Stroke Medication fast acting

The study used 152 people and gave them oral an oral dose of minocycline or placebo for five days post stroke. Researchers then followed both groups for a peroid of three months.

The study found the minocycline group had significantly better outcomes than the placebo group. At the three month period, the test group out performed the placebo group by four times on the National Institutes of Health Stroke Scale, which uses vision, facial palsy, movement, and speaking abilitiy as indicators. The minocycline group had a score of 1.6 which is a level of little or no disability, compared ot a score of 6.5 for the placebo group, which places them in the high end of mild disability.

Researchers say the mechanism of improvement of minocycline is not due to it’s antibiotic effect, but rather its anti-inflammatory effect and protection on brain cells. Other studies have also demonstrated minocycline’s neuroprotective effects. And as an added bonus none of the participants experienced any serious side effects from the drugs.